Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison by Wiebe, Jens, Dörr, Oliver, Ilstad, Hanna, Husser, Oliver, Liebetrau, Christoph, Boeder, Niklas, Bauer, Timm, Möllmann, Helge, Kastrati, Adnan, Hamm, Christian W, Nef, Holger M

Get full text

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease by Wiebe, Jens, MD, Dörr, Oliver, MD, Ilstad, Hanna, Husser, Oliver, MD, PhD, Liebetrau, Christoph, MD, Boeder, Niklas, MD, Bauer, Timm, MD, Möllmann, Helge, MD, Kastrati, Adnan, MD, Hamm, Christian W., MD, Nef, Holger M., MD

Get full text

Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation by Wiebe, Jens, Dörr, Oliver, Liebetrau, Christoph, Bauer, Timm, Wilkens, Eva, Ilstad, Hanna, Boeder, Niklas, Elsässer, Albrecht, Möllmann, Helge, Hamm, Christian W, Nef, Holger M

Get full text